Subscribe

What are you looking for?

Main Menu

明報新聞網

恒瑞醫藥通過上市聆訊

Future Wealths
Future Wealths
5 5 月, 2025
One Min Read
21 Views
0 Comments
恒瑞醫藥（滬：600276）通過上市聆訊，意味有機會短期內在港開始招股活動。聯合保薦人為摩根士丹利、花旗及華泰國際。早前有市場消息指，恒瑞來港集資至少20億美元，相當於156億港元。

原文: https://finance.mingpao.com/fin/instantf/20250505/1746454547756/%e6%81%92%e7%91%9e%e9%86%ab%e8%97%a5%e9%80%9a%e9%81%8e%e4%b8%8a%e5%b8%82%e8%81%86%e8%a8%8a

Last Update: 5 5 月, 2025

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept